AHR and atherosclerosis: Furthermore, the prototypical environmental AhR ligand, 3,4,7,8-tetrachlorodibenzo-p-dioxin (TCDD) has been reported to induce cardiomyopathies, cardiac lesions, arteritis, and atherosclerosis in rodents, and increase the risk of CVD in humans [83].